Temple Terrace, FL, United States of America

Laura Dawn Hamel

This inventor holds 1 USPTO granted patent. Top assignees: Torrey Pines Institute for Molecular Studies, University of South Florida. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura Dawn Hamel. Retrieved from https://idiyas.com/inventor/laura-dawn-hamel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laura Dawn Hamel: A Pioneer in Protein Acyl Transferase Inhibition

Introduction

Laura Dawn Hamel is a distinguished inventor based in Temple Terrace, Florida. With a focus on biotechnology, she has made significant contributions to the field through her innovative research and development. Laura is known for her work on protein acyl transferase inhibitors, which have vital implications for treating various conditions and diseases.

Latest Patents

Laura holds one patent entitled "Protein Acyl Transferase Inhibitors and Methods of Treatment." This patent encompasses compositions and pharmaceutical formulations that include protein acyl transferase (PAT) inhibitors. The innovative methods detailed in her patent are aimed at treating conditions related to autopalmitoylation activity and other related diseases.

Career Highlights

Throughout her career, Laura has worked with notable institutions such as the University of South Florida and the Torrey Pines Institute for Molecular Studies. Her academic and research affiliations have provided her with a rich environment to foster her innovative ideas and develop groundbreaking therapies.

Collaborations

Laura has collaborated with esteemed colleagues in her field, including Robert Joseph Deschenes and Marcello Angelo Giulianotti. These partnerships have enabled her to enhance her research and expand the impact of her findings in the scientific community.

Conclusion

Laura Dawn Hamel stands out as a trailblazer in the realm of protein acyl transferase inhibitors. Her innovative approaches to treatment methodologies highlight her contributions to the field of molecular studies and underscore her commitment to advancing healthcare solutions. As she continues to build upon her research, the potential for her inventions to improve patient outcomes remains promising.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…